Medicine
Showing 701-800 of 1,188 Results
-
Thomas Charles Merigan M.D.
George E. and Lucy Becker Professor of Medicine, Emeritus
Current Research and Scholarly InterestsI am now emeritus and only participate in university activities through advising my former trainees who have joined the faculty.
-
Matthew Mesias
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioMatthew Mesias, M.D., is a Geriatrician and Clinical Associate Professor of Medicine at Stanford University School of Medicine. He completed his medical degree at Johns Hopkins University School of Medicine and furthered his training internal medicine residency and geriatrics fellowship at the University of Washington. He serves as the Medical Director of the Inpatient Geriatrics Consult Service at Stanford University Hospital. His academic interests include quality improvement in geriatric care, mentorship of medical trainees, and the development of curricula for geriatrics medical education. In 2023, he was awarded the HRSA Geriatric Academic Career Award, which supports his leadership and professional development while creating geriatric educational programs for community-partnered clinics.
-
Everett Meyer
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy) and of Pediatrics (Stem Cell Transplantation)
Current Research and Scholarly InterestsResearch focus in T cell immunotherapy and T cell immune monitoring using high-throughput sequencing and genomic approaches, with an emphasis on hematopoietic stem cell transplantation, the treatment of graft-versus-host disease and immune tolerance induction.
-
Timothy Meyer
Stanford University Professor of Nephrology, Emeritus
Current Research and Scholarly InterestsInadequate removal of uremic solutes contributes to widespread illness in the more than 500,000 Americans maintained on dialysis. But we know remarkably little about these solutes. Dr. Meyer's research efforts are focused on identifying which uremic solutes are toxic, how these solutes are made, and how their production could be decreased or their removal could be increased. We should be able to improve treatment if we knew more about what we are trying to remove.
-
Lekha Mikkilineni
Assistant Professor of Medicine (Blood and Marrow Transplantation & Cellular Therapy)
BioDr. Lekha Mikkilineni is a board-certified medical oncologist. She is also an Assistant Professor in the Department of Medicine, Division of Blood & Marrow Transplant and Cellular Therapy.
Dr. Mikkilineni has extensive experience treating blood and bone marrow cancers. She currently provides care through the Bone Marrow Transplant & Cellular Therapy Program at Stanford Health Care. Her clinical focus is multiple myeloma, plasma-cell leukemia, Extramedullary myeloma, high-risk myeloma, CAR T cell therapy, bispecific therapy, amyloidosis, POEMS syndrome, and Waldenstrom’s macroglobunemia.
Dr. Mikkilineni’s research centers on exploring novel CAR T-cell therapies to treat multiple myeloma and to define mechanisms of resistance to immunotherapy. She is particularly focused on understanding how to improve therapies for multiple myeloma patients who have extramedullary disease or high-risk features. Prior to coming to Stanford, she ran phase 1 CAR T-cell trials for multiple myeloma targeting BCMA and SLAMF7 at the National Cancer Institute.
Dr. Mikkilineni received the Conquer Cancer Foundation Young Investigator Award from the American Society of Clinical Oncology for her research focusing on SLAMF7 as a potential target for multiple myeloma. She has received honors and awards for her work at the NCI. She has completed fellowships in hematology/oncology and immunotherapy at the National Heart, Lung, and Blood Institute/National Cancer Institute. She finished her residency in internal medicine at Thomas Jefferson University Hospital. She holds a Master of Science in medical sciences from Boston University and a medical degree from Tulane University.
Dr. Mikkilineni has authored book chapters and published research in numerous high-impact academic journals. She has presented her findings through oral and poster presentations at national and international conferences. -
David Miklos
James and Katherine Lau Professor
Current Research and Scholarly InterestsDr. Miklos is the Chief of BMT & Cell Therapy Program. He leads clinical trials treating patients with lymphoma. His correlative research studies: 1) tumor antigen quantification, 2) single cell functional product characterization, 3) CAR-FACS immune phenotyping of blood and tumor, and identifying mechanisms for CAR-T treatment Failure including antigen loss, CAR-T exhaustion, and CAR suppression.
-
Carlos Milla
Professor of Pediatrics (Pulmonary Medicine) and, by courtesy, of Medicine (Pulmonary, Allergy and Critical Care Medicine)
Current Research and Scholarly InterestsAt Stanford University I developed and currently direct the CF Translational Research Center. The overarching goal of the center is to provide the groundwork to streamline, accelerate, and promote the translation of basic discoveries into effective therapies and interventions to benefit patients affected by cystic fibrosis. My laboratory group currently has three main lines of investigation: respiratory cell biology in CF; remote biochemical monitoring; and lung physiology in young children.
-
Arnold Milstein
Professor of Medicine (General Medical Discipline)
Current Research and Scholarly InterestsDesign national demonstration of innovations in care delivery that provide more with less. Informed by research on AI-assisted clinical workflow, positive value outlier analysis and triggers of loss aversion bias among patients and clinicians.
Research on creation of a national index of health system productivity gain. -
Vijay Mirmira
Adjunct Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Mirmira believes that excellent communication leads to excellent care, and is dedicated to the health and well-being of his patients and their families. He is fluent in English, Hindi, Tamil and Kannada and has working knowledge of Urdu and Telugu. Apart from enjoying practicing the full scope of family medicine, Dr. Mirmira's special interests include diabetes and thyroid disorders, and pediatric illnesses. He likes to travel and read fiction in his free time.
-
Alicia Mirza
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Alicia Mirza is quadruple board-certified in Internal Medicine, Pediatrics, Pulmonary Medicine, and Critical Care Medicine. She is now an Assistant Professor in the Division of Pulmonary, Allergy, and Critical Care Medicine (PACCM) at Stanford, where she serves as Associate Director of the Adult Cystic Fibrosis (CF) Program.
She has expertise across a breadth of pulmonary and intensive care domains, with her clinical and research interests centering on CF and bronchiectasis. She is a CF Foundation (CFF) Program for Adult Care Excellence grant awardee. She has worked on quality improvement projects in adult CF care, including initiatives in advanced care planning, pediatric to adult transitions, primary care utilization, and remote monitoring. She is involved in clinical trials as well as registry-based research in both CF and non-CF bronchiectasis.
Nationally, Dr. Mirza was elected to the CHEST Bronchiectasis Network, where she collaborates with experts across the country to expand education in bronchiectasis through podcasts, training modules, and lectures. An active educator, Dr. Mirza teaches Stanford medical students, residents, and fellows. She is engaged both locally and internationally through conference presentations at CHEST, California Thoracic Society, and the North American CF Conference.
She also serves as Co-director of Wellbeing for Stanford PACCM, where she is committed to advancing faculty wellness and fostering a culture of professional fulfillment. In both her clinical and academic work, she emphasizes a holistic approach to supporting patients and colleagues alike, with attention to the whole person and the systems that sustain their health and wellbeing. -
Beverly S. Mitchell, M.D.
George E. Becker Professor of Medicine, Emerita
Current Research and Scholarly InterestsBeverly Mitchell's research relates to the development of new therapies for hematologic malignancies, including leukemias and myelodsyplastic syndromes. She is interested in preclinical proof of principle studies on mechanisms inducing cell death and on metabolic targets involving nucleic acid biosynthesis in malignant cells. She is also interested in the translation of these studies into clinical trials.
-
Maha Abdalla Mohamed, MD, FACP, FAST
Clinical Associate Professor, Medicine - Nephrology
BioDr. Mohamed is a board-certified, fellowship-trained nephrologist with the Kidney and Pancreas Transplant Program at Stanford Healthcare. She is a clinical associate professor in the Department of Medicine, Division of Nephrology.
Dr. Mohamed specializes in kidney and pancreas transplant outcomes and kidney transplant health equity. Conditions she treats include allografts rejection, recipient BK virus and CMV infection, and post-transplant lymphoproliferative disorder management. Dr. Mohamed is known for her personalized and comprehensive approach to patient care. She takes the time to understand her patients’ unique health needs and creates tailored care plans that fit their lifestyles.
Dr. Mohamed’s research interests include examining new approaches to improving kidney transplant long-term outcome including kidney transplant rejection and infection. She also seeks to develop better screening and monitoring guidance to help reduce post-transplant BK virus and CMV infection.
Dr. Mohamed’s published work can be found in peer-reviewed journals such as Clinical Transplantation, Transplant Infectious Disease and Transplantation. She has presented to her peers at international, national, and regional meetings, including at the American Transplant Congress and the American Society of Nephrology. She has also been invited to speak multiple times at King Faisal Hospital in Rwanda as well as in Kingdom of Saudi Arabia on topics like post-transplant lymphoproliferative disorder, update in kidney transplant rejection, and update in living-donor kidney transplantation.
Dr. Mohamed is a faculty fellow of Stanford Center for Innovation in Global Health, fellow of the American Society of Transplantation, a board of managers member of the AST Transplant Nephrology Fellowship Training Accreditation Program, member of the International Society of Nephrology and the American Society of Nephrology. -
Minal Moharir
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioI was born, raised, and trained in Nashik, India where I completed my formal Medical Education before moving to New York City where I completed my residency in Internal Medicine at New York Downtown Hospital in New York, NY. My interests are in preventative medicne, health and wellness, occupational and environmental safety. In Stanford's Occupational Health Department, I practice clinical occupational medicine while working toward identifying health and safety issues within our enviroment to prevent further injury and illness to our employees.
-
Tamara Montacute, MD, MPH
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioTamara Kailoa Montacute is a board certified Family Medicine physician. She enjoys taking care of the entire family (including kids), and has special interest in women’s health, adolescent health, community health, chronic disease management, mental health and office based procedures. She also speaks Spanish.
She was born in New Zealand, grew up in England and moved to Seattle when she was twelve. Prior to attending medical school at Stanford, she completed her Masters in Public Health at Columbia University and spent several years working on public health programs in Mexico, Panama, Ethiopia and Rwanda. After medical school, she completed a Family Medicine Residency at O’Connor Hospital in San Jose. She is the co-medical director of Arbor Free Clinic, teaches several primary care focused medical student courses and spends part of her time caring for patients at the Samaritan House Free Clinics in Redwood City and San Mateo.
Outside the clinic, she enjoys hiking, biking, gardening and playing with her daughter and 2 dogs. -
Maria Emilia Montez Rath
Assistant Professor (Research) of Medicine (Nephrology)
BioDr. Montez-Rath completed her PhD in Biostatistics from Boston University in 2008 focusing on methods for modeling interaction effects in studies involving populations with high levels of comorbidity, such as persons on dialysis. She is a senior biostatistician and director of the Biostatistics Core of the Division of Nephrology at Stanford University where she has been collaborating with faculty and fellows since 2010 to study a variety of research questions relevant to kidney disease. Her methodological interests are mainly data-driven and include the handling of missing data, survival analysis with an emphasis on models for time-varying covariates and competing risks, methods for analyzing epidemiologic studies, analysis of correlated data and comparative effectiveness studies, as well as data visualization.
-
Joshua Mooney
Clinical Associate Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
Current Research and Scholarly InterestsOutcomes and Health Services Research in Advanced Lung Disease & Lung Transplant
-
Andrew Reese Moore
Instructor, Medicine - Pulmonary, Allergy & Critical Care Medicine
Current Research and Scholarly InterestsI am co-mentored by Dr. Angela Rogers and Dr. Purvesh Khatri. My research focuses on leveraging machine learning on multi-omic data to evaluate the immune response in critical illness. It is striking that despite many years of studying infections, we still treat patients with severe infections the same as we did 30 years ago, with antimicrobials, fluids, and supportive care. The goal of my research is to bring the ideals of precision medicine to critical care. In particular, I am working to better quantify how the immune system responds to infections with the goal of being able to "read" the immune system and treat patients with the medications they need to successfully recover.
-
Nancy Morioka-Douglas, MD, MPH
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly Interests--Community outreach to underserved populations to address health care disparities, chronic illness prevention, and health promotion.
--Chronic illness care: implementing optimal care for these patients and training the next generation of physicians in these best practices.
--Enhancing physician and staff satisfaction in caring for patients -
Meagan Moyer
Academic Staff - Hourly - CSL, Medicine - Primary Care and Population Health
BioI am a lecturer in the School of Medicine's Clinical Informatics Management master of science program. I co-instruct the autumn through spring quarters practicum courses. Students in my courses gain a foundational knowledge of health policy, learn from experts in the field of health technology, and complete a capstone project that brings together learnings from the entire program into a meaningful deliverable that furthers their career and the field of clinical informatics and digital health technology.
-
Alisa Mueller, MD, PhD
Assistant Professor of Medicine (Immunology and Rheumatology)
BioDr. Mueller is an Assistant Professor in the Division of Immunology and Rheumatology. As a physician-scientist, she leads a research laboratory investigating mechanisms that drive stromal pathology in rheumatoid arthritis and other chronic inflammatory conditions. Utilizing innovative techniques in immunology, genomics, and regenerative medicine, she and her team aim to develop novel therapeutic approaches to combat autoimmune diseases.
Dr. Mueller earned her MD and PhD degrees at Stanford University as part of the Medical Scientist Training Program where she investigated mechanisms regulating a mesenchymal progenitor population in skeletal muscle that mediates both healthy tissue regeneration and pathologic fibrosis. During her training, she was awarded predoctoral grants from the NIH National Institute on Aging and the California Institute of Regenerative Medicine. Her studies culminated in a first-author publication in Nature and co-authorship on publications in Cell and Nature Communications. Subsequently, she pursued medicine residency and rheumatology fellowship at Brigham and Women’s Hospital and Harvard Medical School where she explored mechanisms driving synovial fibroblast pathogenicity in rheumatoid arthritis. Her work led to the identification of non-canonical Wnt signaling as a critical mediator of RA synovial fibroblast inflammatory activation as well as the development of functional genomic screens to elucidate a broad set of novel therapeutic targets in inflammatory fibroblasts. Moreover, she has also led high-dimensional immunoprofiling studies to reveal underlying immune aberrations in patients with systemic sclerosis and elucidate biologic mechanisms catalyzing disease in patients with longstanding immune-related disorders of unknown etiology in partnership with the Undiagnosed Diseases Network. During her fellowship and instructorship, she received a Distinguished Fellow Award from the American College of Rheumatology as well as grants including the NIH NIAMS Mentored Clinical Scientist Research Career Development Award (K08), Rheumatology Research Foundation Scientist Development Award with the Malawista Endowment Distinction, Hearst Young Investigator Award, and Innovation Evergreen Fund Award. Her work has resulted in co-first author publications in the Journal of Clinical Investigation, Cell Reports Medicine, and ACR Open Rheumatology as well as as co-authorship on publications in Lancet Rheumatology and the New England Journal of Medicine.
In addition to her scientific endeavors, Dr. Mueller is also dedicated to providing high quality clinical care and education. She serves as an attending physician specializing in rheumatology where she mentors trainees in outpatient and inpatient settings and provides educational lectures. With an interdisciplinary team, she developed an interactive medical case on neurologic manifestations of lupus which was published in the New England Journal of Medicine. She was awarded an Arnold Dunne Award for Compassion and Dedication to Patient Care at Brigham and Women’s Hospital. By pursuing basic and translational research alongside clinical care, Dr. Mueller and her team strive to uncover basic mechanisms regulating stromal biology in autoimmune and inflammatory disease development and to create diagnostic strategies and targeted therapeutics that will benefit patients who do not respond to conventional therapies. -
Lori Muffly
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsDr. Muffly's interests include investigator initiated clinical trials focused on cellular therapies for adults with acute lymphoblastic leukemia and acute myeloid leukemia. She also has an active health outcomes research program focused on patterns of care and improving access to care for adults with acute leukemia.
-
Ann Mullally
George E. Becker Professor in Medicine
Current Research and Scholarly InterestsDr. Ann Mullally's aboratory studies the genetics, biology and therapy of myeloid blood cancers, with a focus on myeloproliferative neoplasms (MPN). Using primary human samples, mouse models, genomics, single-cell sequencing and CRISPR, as well as cellular and molecular biology, the lab has investigated the key genetic events underlying MPN pathogenesis. Dr. Mullally’s lab elucidated the mechanism by which mutant calreticulin (CALR) is oncogenic and causes MPN.
-
Mark Musen
Stanford Medicine Professor of Computational Medicine, Professor of Medicine (Computational Medicine) and of Biomedical Data Science
Current Research and Scholarly InterestsModern science requires that experimental data—and descriptions of the methods used to generate and analyze the data—are available online. Our laboratory studies methods for creating comprehensive, machine-actionable descriptions both of data and of experiments that can be processed by other scientists and by computers. We are also working to "clean up" legacy data and metadata to improve adherence to standards and to facilitate open science broadly.
-
Sanjiv Narayan
Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Narayan directs the Computational Arrhythmia Research Laboratory, whose goal is to define the mechanisms underlying complex human heart rhythm disorders, to develop bioengineering-focused solutions to improve therapy that will be tested in clinical trials. The laboratory has been funded continuously since 2001 by the National Institutes of Health, AHA and ACC, and interlinks a disease-focused group of clinicians, computational physicists, bioengineers and trialists.
-
Neha Narula
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Neha Narula is a Family Physician and Clinical Assistant Professor at Stanford University School of Medicine. She provides comprehensive primary care to a diverse patient population while also teaching medical students and residents. Beyond her clinical work, Dr. Narula serves as a medical correspondent for CBS News and has contributed to publications including The Wall Street Journal, Yahoo News, and USA Today. Her professional interests include Women’s health, Neurology in primary care, Obesity medicine, Integrative and Lifestyle Medicine, as well as Health Equity and Medical Humanities.
-
Ashwin K Nayak
Clinical Assistant Professor, Medicine
Current Research and Scholarly InterestsConversational AI, Large Language Models, Digital Therapeutics
-
Joel Neal, MD, PhD
Professor of Medicine (Oncology)
Current Research and Scholarly InterestsI am a thoracic oncologist who cares for patients with non-small cell lung cancer, malignant mesothelioma, and other thoracic malignancies. I design and conduct clinical trials of novel therapies in collaboration with other researchers and pharmaceutical companies. These generally focus on two areas, 1) targeted therapies against particular mutations in cancers (for example EGFR, ALK, ROS1, HER2, KRAS, MET, and others) and 2) the emerging field of immunotherapy in cancer, using anti PD-1/PD-L1 therapies in combination with other agents, and also developing cellular therapies. I also collaborate with other researchers on campus to apply emerging technologies to cancer therapy, for example, circulating tumor DNA detection. Additionally, in my role as the Cancer Center IT Medical Director, I coordinate projects relating to our use of the electronic health record to improve provider efficiency and facilitate patient care.
-
Robert Negrin
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsOur labaratory focuses on the study of immune recognition by T and NK cells with special emphasis on graft vs host disease and graft vs tumor reactions. We utilize both murine and human systems in an effort to enhance graft vs tumor reactions while controlling graft vs host disease. We have developed bioluminescence models in collaboration with the Contag laboratory to study the trafficking of immune effector cells with a special emphasis on NK, T and regulatory T cells.
-
Joanna Nelson
Clinical Associate Professor, Medicine - Infectious Diseases
BioDr. Nelson is a board certified Infectious Disease specialist. She specializes in the treatment of immunocompromised patients, including patients who have had solid organ or bone marrow transplantation or who have malignancy undergoing chemotherapy. She also has a special interest in caring for patients with Cystic fibrosis or who have had a lung transplant as well as Nontuberculous mycobacterial Infections.
-
Carter Neugarten
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Neugarten is a recognized healthcare leader and national expert at the crossroads of palliative care and emergency medicine. He has published widely in this field, and his initiatives focus on enhancing upstream palliative care accessibility, resource optimization in healthcare, and harnessing telemedicine's potential in providing care.
His contributions include co-chairing a national committee that fosters innovation by merging these fields, and he has received grant funding to study the impact of palliative care referral from the ED.
Dr. Neugarten also has an established footprint in medical education, having held multiple formal teaching roles throughout his career. -
Andrew Nevins
Clinical Professor, Medicine - Infectious Diseases
Current Research and Scholarly InterestsClinical general infectious diseases. Medical education.
-
Andrew Thai Nguyen
Clinical Scholar, Medicine - Cardiovascular Medicine
Postdoctoral Scholar, Cardiovascular MedicineBioDr. Andrew Nguyen is a Cardiologist and a Clinical Scholar in the Department of Medicine, Division of Cardiovascular Medicine. He earned his medical degree from Harvard Medical School in the Harvard-MIT Health Sciences and Technology Program. He then completed his residency in Internal Medicine at Stanford University, followed by fellowship training in Cardiovascular Medicine also at Stanford University.
As a non-invasive cardiologist, Dr. Nguyen cares for patients undergoing cancer therapy as well as cancer survivors in the Stanford Health Care Cardio-Oncology Program. He provides evidenced-based cardiovascular care for patients throughout their cancer journey while managing and preventing treatment toxicities. Dr. Nguyen is a physician scientist who is mentored by Dr. Paul Cheng and Dr. Tom Quertermous. His research blends his clinical interest in cardio-oncology with basic science to understand the complex interplay between cancer angiogenesis and ischemic heart disease. He is a recipient of the AHA Postdoctoral Fellowship Award, ACC/Merck Research Fellowship Award, and NIH F32 Award. -
Linda Nguyen
Clinical Professor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsMy research interests focus on disorder of gastrointestinal motility. Specifically, those related to nausea and vomiting with or without gastroparesis, irritable bowel syndrome and chronic abdominal pain. My research focuses on understanding the cause of symptoms and development of new treatments targeting either symptom control and disease modification.
-
Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
Professor of Medicine (Gastroenterology and Hepatology) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsWe conduct clinical trials and epidemiological, translational, and real-world studies of liver cancer, fatty liver (NASH, NAFLD), viral hepatitis B and C, liver cirrhosis, and liver transplant. We focus on risk identification for disease prevention and treatment for improvement of survival. We focus on sex, racial/ethnic, and socioeconomic disparities. We specialize in clinical trials, large international real-world consortium registry data, and large public/semi-public databases.
-
Quan Dong Nguyen, MD, MSc
Professor of Ophthalmology and, by courtesy, of Pediatrics and of Medicine (Immunology & Rheumatology)
Current Research and Scholarly InterestsWe have focused our research on the development of novel therapies and innovative assessment and diagnostic imaging technologies for retinal vascular and ocular inflammatory disorders, specifically diabetic retinopathy (DR), age-related macular degeneration (AMD) and uveitis. Building on our initial work describing the role of hypoxia and vascular endothelial growth factor (VEGF) in diabetic retinopathy (DR) and diabetic macular edema (DME), We have become interested in the biochemical mechanisms that would presumably lead to DME. During the past decade, our research has contributed to the body of evidences that defines the important role of anti-VEGF therapies in DME and AMD, as well as the role of the mTOR pathway and various interleukins in the pathogenesis of uveitis.
We have launched a productive and well-funded clinical research program while at the same time providing clinical care to patients with uveitis and retinal vascular diseases and fulfilling significant teaching and administrative assignments. We have established a number of key collaborators both within and outside the institutions. In addition, we have also established Center in Baltimore and now in Silicon Valley, which has excelled in conducting proof-of concept, early-phase multi-center clinical trials and studies, exploring the clinical disease manifestations and the efficacy of various pharmacologic agents in retinal, uveitic, and ocular inflammatory disorders. -
Mark Nicolls
Stanford University Professor of Pulmonary and Critical Care Medicine
Current Research and Scholarly InterestsOur lab focuses primarily on the contribution of the immune response to lung disease. We are specifically examining the contribution of inflammation to the development of vascular injury in transplantation, pulmonary hypertension and lymphedema.
-
Koen Nieman
Professor of Medicine (Cardiovascular Medicine) and of Radiology (CV Imaging)
Current Research and Scholarly InterestsDr Nieman investigates advanced cardiac imaging techniques. Current projects focus on the development of functional CT application for hemodynamic interpretation of coronary artery disease, and the clinical validation of cardiac CT in the management of patients with ischemic heart disease.
-
Sankar Narayan Niranjan MD FASN
Clinical Associate Professor, Medicine - Nephrology
BioDr.Niranjan is a nephrologist (specialist in kidney diseases) with specific interests in the care of cancer patients with kidney disease (Onconephrology), high blood pressure (Hypertension) and the prevention of kidney disease.
A graduate of Kilpauk Medical College, India, he completed his medical residencies in the UK and at the University of Connecticut, where he served as Chief Medical Resident and a Nephrology Fellow. Since 2004, he served as an Attending Physician and Nephrologist at the St. Francis Hospital and Medical Center in Hartford, Connecticut, and was a partner at Greater Hartford Nephrology. He was also a Medical Director at DaVita Dialysis in Bloomfield, Connecticut until December 2023.
In addition to his clinical practice, he has mentored numerous young physicians and nephrology trainees as a community-based faculty member at the UCONN School of Medicine in Farmington, Connecticut.
His passion for the prevention and early detection of kidney disease is evident in his active involvement in the National Kidney Foundation’s Kidney Early Evaluation Program (KEEP) in Connecticut. He has facilitated screenings at inner-city community events and minority places of worship, demonstrating his commitment to reaching diverse populations. Over the last five years, he has conducted kidney disease screening camps across Southern India (most recently in June 2024), screening over 500 patients in rural areas using the KEEP template.
At Stanford, Dr.Niranjan sees patients at multiple locations on different days of the week - at the Kidney Clinic, Hypertension Center and Onconephrology clinics catering to different patient populations - all at the 900 Blake Wilbur building location. He also has office hours twice monthly at the Stanford HealthCare Emeryville campus. He is currently faculty at Stanford University School Of Medicine and teaches medical students, residents and fellowship trainees both at bedside and in didactic settings. He is also faculty at the Stanford Center for Asian health research and Education (Stanford CARE). He is a faculty fellow at the Stanford Center for Innovation in Global Health. He holds an administrative title of Director of Community Partnerships in the Division of Nephrology at Stanford Department of Medicine.
Dr.Niranjan is fluent in conversational Tamil, one of the oldest spoken languages in the world. He loves the outdoors and fitness - specifically hiking, bicycling and yoga. He has enjoyed traveling the world with his family. He is passionate about giving back to the community, and supports the education of underprivileged children in India through a US-based non-profit. -
Varalakshmi Niranjan, MD, MBA, Dip ABLM, Dip ABOM
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Varalakshmi Niranjan is triple boarded in Internal Medicine, Obesity Medicine, Lifestyle Medicine and an Author, practicing with Stanford healthcare. Dr. Niranjan practices obesity medicine and lifestyle medicine. Her clinical focus is on prevention and management of chronic diseases including Diabetes Mellitus, Hypertension, Obesity and Chronic Kidney Disease. She is the Founder and Program Director of Cardio metabolic and Lifestyle Medicine program called SMILES - Stanford Metabolic Intervention with Lifestyle Empowerment Support Group.
She is the clinical lead for the ICDP (Improvement Capability Development Program), a joint venture between the Department of Quality for Stanford Healthcare and the Stanford School of Medicine on the management of obesity. She is also the clinical lead for VBC (Value based care) project on MASLD (Metabolic Associated Steatotic Liver Disease) Dr. Niranjan has a special interest in global public health and has conducted a variety of health awareness and wellness camps in rural India.
Dr. Niranjan was the Regional Medical Director of population health for Saint Francis Healthcare Partners in Hartford, Connecticut before joining Stanford University. In her administrative role, she led many projects to improve patient safety and quality. Her research interests include ways to facilitate the teaching of lifestyle medicine, for which she received a Kaiser grant. She also received Food as Medicine Essentials Grant to implement Lifestyle Medicine education for the medical and ancillary staff at the University of Connecticut. She conducts workshops nationwide to teach primary care providers how to manage obesity with lifestyle interventions and medications. She also wrote a guidebook that offers a step-by-step approach for providers to help their patients manage obesity.
Dr. Niranjan has published her work in many peer-reviewed journals, including International Journal of Clinical Practice, Obesity Pillars, and Journal of General Internal Medicine. She is a reviewer for Obesity Pillars and Journal of Brown Hospital Medicine and has presented her work at professional meetings and conferences nationwide. In addition, she has authored several books and e-books, including a health education book and an e-cookbook of vegetarian soups for weight loss.
Dr. Niranjan is a fellow of the American College of Physicians and the Obesity Medicine Association. She is also a member of the American College of Lifestyle Medicine and Society of General Internal Medicine. -
Joyce Njoroge, MD
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Njoroge is a board-certified physician and fellowship-trained cardiologist with the Advanced Heart Failure Program at Stanford Health Care. She is also a clinical assistant professor of medicine in the Division of Cardiovascular Medicine.
Dr. Njoroge has extensive clinical experience diagnosing and treating cardiovascular complications that develop during pregnancy or postpartum. She currently provides care at the Stanford Health Care Heart and Vascular Clinic with a particular focus on patients with a history of pregnancy-associated heart failure and cardiomyopathy.
Dr. Njoroge’s research efforts involve identifying inherited genetic changes and biological markers that could help improve screening and care for pregnant women in higher risk populations. This includes determining the causes of disproportionately high incidences of heart-related complications and deaths experienced by Black women during and after pregnancy. Dr. Njoroge is also currently recruiting patients for a large-scale, multicenter clinical trial evaluating a drug to treat cardiovascular complications during pregnancy.
Dr. Njoroge has published her work in numerous prestigious peer-reviewed journals, including Circulation Research and the Journal of Cardiac Failure. She also co-authored a chapter on cardiovascular disease in pregnancy in the most recent edition of the book Current Diagnosis and Treatment: Cardiology.
Dr. Njoroge is a member of the Association of Black Cardiologists, the American College of Cardiology, the American Heart Association, and the Heart Failure Society of America. -
Dale Gene O'Brien
Adjunct Clinical Assistant Professor, Medicine - Oncology
BioDale O’Brien, MD, MPH is adjunct faculty at the Stanford University School of Medicine in the Oncology Division. He founded several medical clinics for vulnerable populations in under-resourced areas of northern California where he has been a practicing physician for more than four decades.
A graduate of the University of Missouri School of Medicine, he took postgraduate training at the Oregon Health & Science University, and the University of California (San Francisco) / University of California School of Public Health. He is board certified by the American Board of Family Medicine and by the American Board of Preventive Medicine.
Dr. O'Brien treated hippies at the White Bird Clinic in Eugene, Oregon in the mid-70s; served as the acting Health Officer of the Shasta County Health Department in California; and spent two years in the early 80s as an affiliate of the European Branch Headquarters of the World Health Organization in Denmark.
As the Executive Director of the nonprofit Cancer Patients Alliance (CPA) since 2001, Dr. O’Brien and his team have advocated for and supported low-income Latino community members, immigrants and farm workers with cancer in the Salinas Valley agricultural region of Monterey County, California.
Dr. O’Brien was Co-Principal Investigator of the Stanford Cancer Institute's Developmental Research Award in Translational Science, "Building an Academic-Community Partnership to Understand and Address Barriers to Cancer Care in the Salinas Valley Region of Monterey County," 2010 – 2015.
CPA has trained a number of Stanford University medical and post-doctoral students on behalf of the Valley Fellowship Program beginning in 2010 until the present.
Dr. O'Brien was a member of the Stanford / Medable team that developed the cancer aftercare app called TOGETHERCare - per NIH / NCI (SBIR 363) Phase 1 and 2 grants from 9/18/2017 until 9/30/2022.
Dr. O’Brien was on the Stanford-based research team in 2018 that piloted and studied the efficacy of the “Healthkey” behavioral health app for SAMHSA, CDC and the Council of State and Territorial Epidemiologists.
Beginning 2019, he was Co-Principal Investigator with the Stanford University group that has helped reduce cancer disparities by increasing access to the emerging DNA technologies - and facilitating cultural translation in Monterey County - pursuant to 4-year support from the California Initiative to Advance Precision Medicine.
In 2021, CPA received a 5-year grant award from the Robert Wood Johnson Foundation to further their advocacy work with the Latino community and farm workers with cancer in the Salinas Valley.
In June 2021, CPA was selected by the California GOTV medical academic consortium including the Stanford University School of Medicine as led by UCLA - to conduct the "Get Out the Vaccine to Stop Covid-19" initiative for low-income populations in Monterey County, California.
Dr. O'Brien was awarded a grant from SAMHSA through the California Department of Health Care Services (administered by Sierra Health Foundation) as the Lead for the 2024-2025 collaborative consisting of CPA, Monterey County Behavioral Health, Mujeres en Acción, and NAMI Monterey County for the "Behavioral Health Recovery, Access and Equity for Latinos" (BHRAEL) initiative.
Since 2016 Dr. O'Brien has been on the Institutional Review Board of Clinica de Salud del Valle de Salinas. He is currently a member of the Stanford Cancer Institute Community Advisory Board. Dr. O’Brien is a past editor of the Berkeley Wellness Letter, Medicine on the Net and Cancer Informatics. -
John Openshaw
Assistant Professor of Medicine (Infectious Diseases and Geographic Medicine)
Current Research and Scholarly InterestsMy research laboratory addresses questions at the intersection of infectious diseases and environmental change. We use field, laboratory, and computational approaches and our work ranges from basic epidemiologic and risk-factor studies to serologic surveys to developing new data collection tools and pathways.
-
Lars Osterberg, MD, MPH
Current Research and Scholarly InterestsBarriers to Humanism
Collaborative Faculty Development in Improving Humanism and Professionalism
Using Radiofrequency Identificaton technology to improve medication adherence
Impact of Learning Communities on Medical Education -
Linda K. Ottoboni, PhD, CNS
Clinical Assistant Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsLearning more about the patient lived experiences with cardiac arrhythmias and their perceived resources believed to provide support to achieve Quality of Life.
-
Natalie Pageler
Clinical Professor, Clinical Informatics
Clinical Professor, Computational MedicineCurrent Research and Scholarly InterestsIn my administrative role, I oversee the development and maintenance of clinical decision support tools within the electronic medical record. These clinical decision support tools are designed to enhance patient safety, efficiency, and quality of care. My research focuses on rigorously evaluating--1) how these tools affect clinician knowledge, attitudes, and behaviors; and 2) how these tools affect clinical outcomes and efficiency of health care delivery.
-
Neda Pakdaman
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Pakdaman practices Internal Medicine in Silicon Valley. She received her medical education at Yale University School of Medicine where she earned the Janet M. Glasgow Memorial Achievement Award for Women in Medicine. She completed her residency in Internal Medicine at Stanford University Hospital and was nominated for the Alwin Rambar-James Mark Award for Excellence in Patient Care.
Dr. Pakdaman has been involved in developing innovative models for patient centered practice delivery. She has extensive background in Concierge Medicine as well as Executive Medicine. In addition, prior to coming to Stanford, she helped initiate and served as medical director for the Palliative Care inpatient consult service at El Camino Hospital. During that time, she served as chair of the El Camino Hospital Ethics Committee and as an advisory member for the Genomics Medicine Institute at El Camino Hospital. Drawing from her experiences working in both executive health programs and retainer based practices, she joined Stanford in 2012 to help launch Stanford Concierge Medicine. She subsequently served as the Medical Director of Stanford Concierge Medicine and Stanford Executive Health for five years where she helped pilot aspects of Stanford Precision Health platform.
Dr. Pakdaman's clinical focus is adult primary care with health promotion and disease prevention/management.
Board Certified Internal Medicine 2003, 2013
Board Certified Hospice and Palliative Medicine 2008, 2018 -
Latha Palaniappan, MD, MS
Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsDr. Palaniappan has published over 200 peer reviewed manuscripts, abstracts, and book chapters over the last 20 years in the areas of chronic disease prevention and treatment in diverse populations. She has expertise in epidemiological research using big data, use of electronic health records for research, and clinical trials.
-
Minggui Pan, MD, PhD
Clinical Professor, Medicine - Oncology
BioDr. Pan is a board-certified, fellowship-trained medical oncologist with the Stanford Medicine Cancer Center and a clinical professor in the Department of Medicine, Division of Oncology.
He diagnoses and treats various oncological conditions and specializes in the treatment of bone and soft tissue sarcoma. He creates personalized and comprehensive care plans for each patient he serves.
Dr. Pan’s research focuses include understanding how genomic alterations impact the biological behavior and prognosis of sarcomas. In his work, he identifies new targets for developing innovative therapeutics for sarcoma treatment.
Dr. Pan has numerous publications and presented dozens of abstracts in several cancer and immunology conferences. His papers have been published in the Journal of Clinical Oncology, JCO Precision Oncology, Clinical Cancer Research, Nature Review Clinical Oncology, Nature Nanotechnology, Frontier Endocrinology, JCO Oncology Practice, Journal of Hematology and Oncology, British Journal of Cancer Reports, and other peer-reviewed journals. He has also presented to his peers at international, national, and regional meetings, including the annual meetings of American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR), European Society for Medical Oncology (ESMO), Chinese Society Of Clinical Oncology (CSCO), Connective Tissue Oncology Society (CTOS) and others.
Dr. Pan is a member of American Society of Clinical Oncology, American Association for Cancer Research, American Association of Immunologists, American Association for Advancement of Science, Society for Immunotherapy of Cancer, and Connective Tissue Oncology Society. Dr. Pan is also an adjunct investigator with Kaiser Permanente Division of Research. -
Alan C. Pao
Associate Professor of Medicine (Nephrology) and, by courtesy, of Urology
Current Research and Scholarly InterestsWe are broadly interested in how the kidneys control salt, water, and electrolyte homeostasis in the body. Our disease focus is on kidney stone disease. We use cultured kidney cells, transgenic mice, human plasma/urine samples, and electronic health record data to study the pathogenesis of kidney stone disease. Our therapeutic focus is on the development of small molecule compounds that can be used for kidney stone prevention.
-
Divya Parikh, MD
Clinical Assistant Professor, Medicine - Oncology
BioDr. Divya Parikh is board-certified in both medical oncology and internal medicine. She obtained her medical degree from Boston University School of Medicine and completed both her residency and fellowship through Stanford University. During her fellowship, she simultaneously earned a Master of Science in health policy from Stanford University.
Dr. Parikh specializes in the care of patients with genitourinary cancers. In addition to her clinical responsibilities, she currently is a clinical assistant professor of medical oncology at Stanford School of Medicine. She mentors medical residents and fellows by sharing her insights, knowledge, and expertise.
Dr. Parikh has a strong research background. She has published in multiple academic journals and presented her findings through poster and oral presentations at various medical conferences. -
Victoria Parikh, MD
Associate Professor of Medicine (Cardiovascular Medicine)
BioDr. Parikh is a clinician scientist who cares for patients with and studies inherited (genetic) cardiovascular disease. She is the director of the Stanford Center for Inherited Cardiovascular Disease (SCICD) which is one of the largest of its kind in the country. SCICD integrates clinical and basic science with the expert care of patients with genetic cardiovascular conditions (e.g., cardiomyopathies, arrhythmias and vascular diseases). It provides cutting edge care for thousands of patients and families across the lifespan and integrates medical, surgical and genetics care. Our team includes physicians, nurses, advanced practice providers, genetic counselors, exercise physiologists and scientists.
Dr. Parikh's own clinical practice and laboratory are focused on the genetics of cardiomyopathies and their associated arrhythmogenic substrates. She completed clinical cardiology fellowship at Stanford School of Medicine and her medical residency at the University of California, San Francisco. Funded by multiple research grants from the NIH, her lab seeks to identify novel mechanisms and therapeutic technologies for genetic cardiomyopathy as well as better understand the natural histories of patients affected by these diseases. -
Albert Park, MD
Clinical Assistant Professor, Medicine
BioAlbert Park, MD, is a Clinical Assistant Professor and academic hospitalist in the Division of Hospital Medicine at Stanford University School of Medicine. He earned his MD from Harvard Medical School and completed his internal medicine residency at Stanford, where he subsequently served as Chief Resident.
His academic interests span clinical outcomes research and medical education. He approaches research through retrospective and observational methods, with interests that include infectious disease and critical care. As an educator, he is drawn to bedside teaching and clinical reasoning, and has worked with medical students and residents across inpatient settings throughout his training. Clinically, he is dedicated to ensuring that patients and families feel informed and supported throughout their hospitalization, with a particular commitment to translating the complexity of acute illness into clear, accessible language. -
Walter Park
Professor of Medicine (Gastroenterology and Hepatology)
Current Research and Scholarly InterestsDr. Park's research interests are in the diagnosis and management of pancreatic cysts, acute and chronic pancreatitis. His approach incorporates methods in health services research including the use of observational datasets, cost-effectiveness studies, and the development of clinical cohorts.
